In this short video, some of the leading figures in the pharma industry talk disruption and transformation-Brexit, US pricing pressures, and the rise of ultra-expensive gene and cell therapies-all subjects to be explored in more depth at this year's FT Pharmaceutical and Biotech Conference on November 11-12 in London. Longer individual interviews can be seen on the FT Live channel's playlist. Further information about the conference, visit live.ft.com/pharmabio
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.